MedTech Strategist | MedTech's Most Trusted Source
@MedTechStrat
Followers
4K
Following
12K
Media
4K
Statuses
9K
Professional, premium content for #medtech leaders and executives through our publications and global medical device conferences. RTs ≠ endorsement.
Opportunities for You ➡️
Joined January 2016
SAVE THE DATE: San Diego's #medicaltechnology sector has grown into a leading hub for medical technology and diagnostic innovation in the U.S. Join 300+ #medtech leaders, investors, and innovators from November 19-21, 2025 for exclusive insights, strategic networking, and key
1
1
7
Present your #medtech startup at #InnovationSanDiego — where real investor access meets real partnering opportunities. Apply today to be a presenting company:
1
0
0
Research you need to see. -
0
0
0
NEW COMMUNITY NEWSLETTER: From policy to innovation: what's ahead of medtech. -
1
0
1
If you’re serious about #medtech innovation, you need to be in San Diego this November. Top leaders from HSBC, BTIG, @OrbiMed, @JNJMedTech, and Elevage are speaking—don’t miss your chance to connect: #InnovationSanDiego
1
0
0
Endometriosis ($180–250B) & menopause ($120–350B) markets rival top global therapeutic areas. The @womensbrainpro shows why sex- & gender-specific precision #medicine is a commercial & clinical imperative. Read more w/ a free trial of MedTech Strategist:
1
0
2
Strong PR is a #medtech growth engine. @MarjieHadad explains how clear messaging and earned media can drive trial enrollment, partnerships, and financings—while avoiding common pitfalls. Read her insights in this Q&A: #MedTech
1
0
2
What if there was a valve to restore blood flow in diseased veins? @enVVenoMedical's VenoValve could do just that for patients with chronic venous insufficiency. Backed by pivotal trial data, this first-of-its-kind device may redefine treatment for a condition affecting 1 in 20
0
1
2
What the numbers reveal. These are the charts investors are paying attention to. -
0
0
2
What does it take to turn a #medtech startup into a success story? At #InnovationSanDiego, industry leaders will share insights on scaling innovation, securing investment, and building the right partnerships:
1
3
6
Millions of patients don’t respond to conventional migraine therapies. @Shiratronics_i is developing a purpose-built neuromodulation system to change that. Backed by strong data and $108M in funding, the start-up is aiming to transform chronic migraine care:
0
0
3
RT @Market_Pathways: Stay ahead in #medtech. Get your free feature article from @Market_Pathways for:.• Expert market access analysis.• K….
0
2
0
Is life sciences dealmaking resetting—or stalling out?. Figure 3 infographic shows values swing, volumes fall, and investors retreat to safer, later-stage bets. Biotech struggles, #medtech steadies. Full breakdown here:
1
0
3
RT @MedTechStrat: CVI affects 1 in 20 U.S. adults, and @enVVenoMedical is tackling it head-on with VenoValve & enVVe. 84% of patients in th….
0
1
0
RT @MedTechStrat: Top strategics join #InnovationSanDiego: @Medtronic, @JNJMedTech, @bostonsci, @Olympus_Corp, @EdwardsLifesci & @AbbottNew….
0
2
0
RT @MedTechStrat: The @Shiratronics_i Discure MSI targets occipital & supraorbital nerves with constant stimulation to reduce pain & restor….
0
1
0
RT @MedTechStrat: Buyer perception of risk shapes #medtech M&A success. Peter Meyer, PhD, & Oded Ben-Joseph, PhD, MBA, share how sellers ca….
0
1
0
RT @Market_Pathways: FDA #device user fees are rising again—FY 2026 includes a 23% hike in facility registration fees. But with staff cuts….
0
1
0
Buyer perception of risk shapes #medtech M&A success. Peter Meyer, PhD, & Oded Ben-Joseph, PhD, MBA, share how sellers can align with acquirer priorities & boost deal value. Full article here:
0
1
3
The @Shiratronics_i Discure MSI targets occipital & supraorbital nerves with constant stimulation to reduce pain & restore quality of life for chronic migraine patients: #medtech
0
1
4